Skip to content

IMA

ImageneBio Inc

NASDAQ · USHealthcareBiotechnology
$5.73+6.51%

Price as of Jul 20, 2026

IMA capital

ImageneBio Inc capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.07x
Net debt / equity
-0.55x
Debt / assets
0.06x
Debt / EBITDA
-0.16x
Net debt / EBITDA
1.31x

Liquidity & coverage

Current ratio
18.39x
Quick ratio
18.39x
Cash ratio
17.67x
Interest coverage
-582.57x
EBITDA / interest
-537.91x
Working capital
$115.4M

Cash & dividend

FCF / debt
-6.39x
Cash flow / debt
-6.39x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.